# E-DRUG: Re: Sulphamethoxypyridazine/Pyrimethamine

**URL:** <https://talk.edrugplus.org/t/e-drug-re-sulphamethoxypyridazine-pyrimethamine/3171>\
**Category:** e-drug\
**Created:** [July 28, 1998, 7:50pm UTC](https://talk.edrugplus.org/t/e-drug-re-sulphamethoxypyridazine-pyrimethamine/3171 "1998-07-28T19:50:58Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![lo1](https://avatars.discourse-cdn.com/v4/letter/l/e68b1a/32.png) [@lo1](https://talk.edrugplus.org/u/lo1)\
**Post date:** [July 28, 1998, 7:50pm UTC](https://talk.edrugplus.org/t/e-drug-re-sulphamethoxypyridazine-pyrimethamine/3171/1 "1998-07-28T19:50:58Z")

</div>

E-drug: Re: Sulphamethoxypyridazine/Pyrimethamine  
----------------------------------------------------------

Please tell us in which country you are working - whether  
registration of this old combination is appropriate depends on the  
region where it is used.

Best wishes.  
Leo Offerhaus MD PhD  
Koedijklaan 1a, NL-1406KW Bussum, the Netherlands  
Phone +31-35-6923288 Fax +31-35-6923290  
E-mail: LO@EURONET.NL or CompuServe 71530,15  
EJCP Only: POB 75552, NL-1070AN Amsterdam

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
